Proteomics in thyroid cancer and other thyroid-related diseases: A review of the literature
- PMID: 32712303
- DOI: 10.1016/j.bbapap.2020.140510
Proteomics in thyroid cancer and other thyroid-related diseases: A review of the literature
Abstract
Misdiagnosis, over-diagnosis, or inappropriate treatment strategies are frequently seen in thyroid disease management. Currently, there is an urgent interest to identify biomarkers for specific disease states in the thyroid gland. Proteomics-based approaches have been widely used for the discovery of potential biomarkers in thyroid research. Specifically, proteomic techniques have been used to better understand thyroid tumors of different origin and classification. Besides, there is remarkable thyroid proteomics research in thyroid-related diseases, including thyroid orbitopathy. In this review, we aim to describe proteomic studies and how the results obtained from thyroid cancer, up to now, as well as those from, other thyroid-related diseases pose challenges, which might be solved via high-resolution protein analysis.
Keywords: Biomarker; Cancer proteomics; Proteomics; Thyroid cancer; Thyroid orbitopathy.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest No potential conflicts of interest were disclosed.
Similar articles
-
Proteome analysis in thyroid pathology.Expert Rev Proteomics. 2015 Aug;12(4):375-90. doi: 10.1586/14789450.2015.1062369. Epub 2015 Jul 1. Expert Rev Proteomics. 2015. PMID: 26132359 Review.
-
Thyroid-associated orbitopathy and tears: A proteomics study.J Proteomics. 2018 Jan 6;170:110-116. doi: 10.1016/j.jprot.2017.09.001. Epub 2017 Sep 5. J Proteomics. 2018. PMID: 28887209 Clinical Trial.
-
Thyroid tumors: novel insights from proteomic studies.Expert Rev Proteomics. 2009 Aug;6(4):363-76. doi: 10.1586/epr.09.51. Expert Rev Proteomics. 2009. PMID: 19681672 Review.
-
Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.Oncologist. 2018 Dec;23(12):1415-1425. doi: 10.1634/theoncologist.2017-0399. Epub 2018 May 8. Oncologist. 2018. PMID: 29739896 Free PMC article.
-
High-resolution proteomics and metabolomics in thyroid cancer: Deciphering novel biomarkers.Crit Rev Clin Lab Sci. 2017 Nov-Dec;54(7-8):446-457. doi: 10.1080/10408363.2017.1394266. Epub 2017 Oct 30. Crit Rev Clin Lab Sci. 2017. PMID: 29084467 Review.
Cited by
-
Peptidomics Unveils Distinct Acetylation Patterns of Histone and Annexin A1 in Differentiated Thyroid Cancer.Int J Mol Sci. 2023 Dec 27;25(1):376. doi: 10.3390/ijms25010376. Int J Mol Sci. 2023. PMID: 38203548 Free PMC article.
-
Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer.Int J Mol Sci. 2023 Sep 26;24(19):14542. doi: 10.3390/ijms241914542. Int J Mol Sci. 2023. PMID: 37833989 Free PMC article.
-
Surgical Management of Indeterminate Thyroid Nodules across Different World Regions: Results from a Retrospective Multicentric (the MAIN-NODE) Study.Cancers (Basel). 2023 Aug 7;15(15):3996. doi: 10.3390/cancers15153996. Cancers (Basel). 2023. PMID: 37568811 Free PMC article.
-
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs).Int J Mol Sci. 2023 Jan 29;24(3):2567. doi: 10.3390/ijms24032567. Int J Mol Sci. 2023. PMID: 36768889 Free PMC article.
-
An overview of deep learning applications in precocious puberty and thyroid dysfunction.Front Endocrinol (Lausanne). 2022 Oct 20;13:959546. doi: 10.3389/fendo.2022.959546. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36339395 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
